AG0032GC

19685-09-7 | (4S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione

Chemical structure of (4S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, CAS 19685-09-7
AG0032GC
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 19685-09-7
Catalog Number AG0032GC(AGN-PC-0QOK9X)
Chemical Name (4S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
IUPAC Name (19S)-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
InChI InChI=1S/C20H16N2O5/c1-2-20(26)14-7-16-17-11(5-10-6-12(23)3-4-15(10)21-17)8-22(16)18(24)13(14)9-27-19(20)25/h3-7,23,26H,2,8-9H2,1H3/t20-/m0/s1
InChI Key HAWSQZCWOQZXHI-FQEVSTJZSA-N
MDL Number MFCD00189425
Molecular Formula C20H16N2O5
Molecular Weight 364.3514
NSC Number 107124
SMILES O=C5[C@](O)(CC)C(C=C34)=C(CO5)C(N3CC2=C4N=C1C=CC(O)=CC1=C2)=O
UNII 9Z01632KRV
Synonyms
10-hydroxycamptothecin, 10-hydroxycamptothecine, 10-Hydroxycamptothecin, 19685-09-7, (S)-10-Hydroxycamptothecin, Hydroxycamptothecin, 10-hydroxycamptothecine, 10-Hydroxy camptothecin, Hydroxycamptothecine, Camptothecin, hydroxy-, 10-Hydroxy-Camptothecin, (S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, Camptothecin, 10-hydroxy-, Camptothecine, 10-hydroxy-, 10-HCPT, NSC 107124, UNII-9Z01632KRV, HCPT, (4S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, (S)-10-Hydroxycamptothecin hydrate, NSC107124, CHEMBL273862, (20S)-10-Hydroxycamptothecin, CHEBI:81395, 9Z01632KRV, (+)-(S)-10-HYDROXYCAMPTOTHECIN, AK-33939, Camptothecin, 10-Hydroxy-, Camptotheca acuminata, (S)-4-ethyl-4,9-dihydroxy-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione, 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4,9-dihydroxy-, hydrate, (S)-, Q-100241, Hydroxy camptothecine, (20S)-4-Ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione, 10-Hydroxycamptochecin, CAMPTOTHECIN, 10-HYDROXY, 10-Hydroxy-CPT, 10-Hydroxycampothecin, 10hydroxy camptothecin, Hydroxycamptothecin-10, PubChem13092, Spectrum_001639, SpecPlus_000763, Spectrum2_001660, Spectrum3_001621, Spectrum4_001815, Spectrum5_000549, ethyl(dihydroxy)[?]dione, 7-ethy hydroxycamptothecin, AC1L3Y2F, AC1Q6AQ3, (4s)-4-ethyl-4,9-dihydroxy-1h-pyrano[3',4':6,7]indolizino[1,2-b]chinolin-3,14(4h,12h)-dion, SCHEMBL25875, BSPBio_003281, KBioGR_002454, KBioSS_002119, DivK1c_006859, SPECTRUM1504123, SPBio_001819, CTK8B3047, KBio1_001803, KBio2_002119, KBio2_004687, KBio2_007255, KBio3_002501, EX-A988, HAWSQZCWOQZXHI-FQEVSTJZSA-N, (+/-)-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLINE-3,14(4H,12H)-DIONE, AOB33756, BCP01385, EBD37036, HY-N0095, ZINC3979155, Camptothecine, 10-hydroxy- (8CI), 2136AH, ANW-41680, BDBM50008922, CCG-38770, CH-068, CH0082, MFCD02093100, s2423, AKOS015919293, AC-5502, ACN-035239, AN-1351, BCP9000058, CS-5193, DB12385, NSC-107124, RL02475, 4-Ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione, NCGC00095986-01, NCGC00095986-02, NCGC00095986-03, NCGC00095986-04, NCGC00178165-01, AC-13221, AJ-47579, AN-38748, AS-13196, BR-33939, H577, NCI60_000173, SC-19239, AB0013128, AX8001153, LS-127397, TL8001609, TR-009134, FT-0607192, FT-0689364, N2591, ST24032108, 10-hydroxycamptothecin;10-hydroxy camptothecin, 85H097, A11997, A25382, C17939, M-1114, (S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4', C-20977, SR-05000002620, SR-05000002620-1, BRD-K63784565-001-02-1, BRD-K63784565-001-03-9, (4S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 10-Hydroxycamptothecin; 10-Hydroxycamptothecine; NSC 107124, (alphaS)-alpha,2-Dihydroxy-alpha-ethyl-8-(hydroxymethyl)-9-oxo-9,11-dihydroindolizino[1,2-b]quinoline-7-acetic acid 7,8-lactone, (S)-10-Hydroxycamptothecin;-;(+/-)-4-ethyl-4,9-dihydroxy-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione, (S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione ((S)-10-Hydroxycamptothecin), 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione-,4-ethyl-4,9-dihydroxy-, (S)-, 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione-,4-ethyl-4,9-dihydroxy-, (S)- (9CI), 1H-Pyrano[3',7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione-,4-ethyl-4,9-dihydroxy-, (S)-, 4-Ethyl-4,10-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione, 4-Ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione (10-hydroxycamptothecin), HCPT cpd, hydroxycamptothecinum, 10-Hydroxycamp-totecin, 10 hydroxy Camptothecin, D07ILP, C20H16N2O5, KST-1A7243, CID97226, AR-1A6082, CS-O-06296, C20-H16-N2-O5.H2-O, H1463, 64439-81-2, C028098, C527042, 67656-30-8, 6628-69-9, 10-Hydroxycamptothecin, 98%, from Taxus chinensis (Pilg.) Rehder - 10MG 10mg, (S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14-(4H,12H)-dione, 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione-,4-ethyl-4,9-dihydroxy-, (S)-,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited